Skip to main content
. 2019 Jun;7(12):252. doi: 10.21037/atm.2019.04.63

Table 2. Outcomes in Crohn’s diseases with cannabis vs. no cannabis.

Complications No cannabis (n=3,003) Cannabis (n=2,999) P value
Disposition of patient <0.001#
   Routine 2,579 (85.9%) 2,610 (87.0%)
   Transfer to short-term hospital 50 (1.7%) 45 (1.5%)
   Other transfers (SNF, ICF, other facility) 56 (1.9%) 35 (1.2%)
   Home health care 159 (5.3%) 101 (3.4%)
   Against medical advice 159 (5.3%) 209 (7.0%)
Anemia 903 (30.1%) 767 (25.6%) <0.001#
Hypovolemia 15 (0.5%) 35 (1.2%) 0.004#
Fluid and electrolyte disorders 1,047 (34.9%) 1,062 (35.4%) 0.664
Active fistulizing disease or intraabdominal abscess 177 (5.9%) 257 (8.6%) <0.001#
Stricturing diseases 274 (9.1%) 261 (8.7%) 0.570
Intestinal obstruction 575 (19.1%) 614 (20.5%) 0.198
Unspecified lower gastrointestinal hemorrhage 80 (2.7%) 120 (4.0%) 0.004#
Malnutrition 176 (5.9%) 162 (5.4%) 0.441
C. diff 74 (2.5%) 54 (1.8%) 0.075
Colorectal cancer 36 (1.2%) <11* <0.001#
Small intestinal and colorectal resection 197 (6.5%) 183 (6.1%) 0.468
Blood transfusion 173 (5.8%) 171 (5.7%) 0.922
Parenteral nutrition 141 (4.7%) 91 (3.0%) 0.001#
Length of stay (days) (mean ± SD) 5.0±5.3 4.2±3.9 <0.001#
Total charges per admission $35,180 $28,956 <0.001#

#, P<0.05 indicates statistical significance. Cell counts <11 are indicated by * as per HCUP privacy guidelines. SNF, skilled nursing facility; ICF, intermediate care facility.